Shell plc (SHEL.L)
London, GB
Shell plc is a global energy and petrochemical enterprise with operations spanning across Europe, Asia, Oceania, Africa, and the entirety of the Americas. Its diverse activities are structured into key divisions: Integrated Gas, Upstream, Marketing, Chemicals and Products, and Renewables and Energy Solutions. The company's upstream endeavors include the exploration and extraction of crude oil, natural gas, and associated liquids. It also handles the marketing and transportation of these resources, producing gas-to-liquids fuels, and maintaining the vital infrastructure required to bring gas to consumers. Beyond extraction, Shell actively engages in trading and marketing natural gas, liquefied natural gas (LNG), crude oil, electricity, and carbon credits. A significant focus is also placed on supplying LNG as a fuel source for heavy transportation and marine applications. Its downstream operations involve the trading and refinement of crude oil and various feedstocks, yielding a broad array of products such as low-carbon fuels, lubricants, bitumen, sulphur, gasoline, diesel, heating oil, aviation fuel, and marine fuel. Shell further produces and sells petrochemicals for industrial applications and oversees oil sands operations. Within its chemical division, Shell manufactures foundational chemicals like ethylene, propylene, and aromatics, alongside a range of intermediate chemicals including styrene monomer, propylene oxide, solvents, detergent alcohols, ethylene oxide, and ethylene glycol. In its commitment to energy transition, the firm generates electricity from renewable sources such as wind and solar, produces and distributes hydrogen, offers electric vehicle charging infrastructure, and develops electricity storage solutions. Founded in 1907, Shell plc, originally incorporated as Royal Dutch Shell plc before adopting its current name in January 2022, maintains its headquarters in London, United Kingdom.
3 articles
- Coiled Therapeutics develops improved formulation of experimental cancer drug ahead of trial expansion Proactive Investors - Finance
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.66% | +0.02% | -7.05% | +10.09% | +9.30% | +16.04% | +27.59% | +31.98% | +134.86% | +83.10% | +1,090.82% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | -1 |
| Buy | 5 | -1 |
| Hold | 11 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Oil & Gas Integrated: -4.1%-4.2% Q1'26: -1.5% (vs Q1'25)
-
EPS growth Oil & Gas Integrated: +4.4%+21.0% ★ Q1'26: +30.7% (vs Q1'25)
-
FCF margin FCF growth · Oil & Gas Integrated: -6.1%+6.7% Q1'26: +2.3% (vs Q1'25)
-
EBIT margin Oil & Gas Integrated: +12.4%+12.3% Q1'26: +14.9% (vs Q1'25)
-
ROIC Oil & Gas Integrated: +5.6%+8.2% ★ Q1'26: +11.0% (vs Q1'25)
-
Share dilution Oil & Gas Integrated: +0.6%-6.5% ★ Q1'26: -10.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Oil & Gas Integrated: 0.90×1.86× Q1'26: 1.20× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 14 Rev. Ana. 11 EPS Ana. |
Dec 2027 17 Rev. Ana. 14 EPS Ana. |
Dec 2028 14 Rev. Ana. 6 EPS Ana. |
Dec 2029 9 Rev. Ana. 4 EPS Ana. |
Dec 2030 13 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
264.96B
est: 272.89B (-2.9%)
|
233.59B
est: 238.22B (-1.9%)
|
305.18B
est: 292.36B (+4.4%)
|
388.38B
est: 397.99B (-2.4%)
|
344.88B
est: 332.13B (+3.8%)
|
180.54B
est: 212.54B (-15.1%)
|
261.50B
est: 279.51B (-6.4%)
|
381.31B
est: 398.27B (-4.3%)
|
316.62B
est: 382.27B (-17.2%)
|
284.31B
est: 300.96B (-5.5%)
|
272.49B
est: 270.26B (+0.8%)
|
318.77B
258.56B – 435.93B
+18.0% YoY
|
293.48B
271.44B – 350.48B
-7.9% YoY
|
293.58B
253.85B – 377.53B
+0.0% YoY
|
298.65B
258.23B – 384.05B
+1.7% YoY
|
298.86B
258.41B – 384.32B
+0.1% YoY
|
| EBITDA |
30.69B
est: 47.95B (-36.0%)
|
34.10B
est: 41.86B (-18.5%)
|
48.28B
est: 51.37B (-6.0%)
|
60.90B
est: 69.94B (-12.9%)
|
55.15B
est: 58.36B (-5.5%)
|
2.22B
est: 37.35B (-94.0%)
|
56.51B
est: 49.12B (+15.0%)
|
92.55B
est: 69.99B (+32.2%)
|
60.36B
est: 81.98B (-26.4%)
|
61.65B
est: 64.54B (-4.5%)
|
56.13B
est: 57.96B (-3.2%)
|
68.36B
55.45B – 93.49B
+18.0% YoY
|
62.94B
58.21B – 75.16B
-7.9% YoY
|
62.96B
54.44B – 80.96B
+0.0% YoY
|
64.05B
55.38B – 82.36B
+1.7% YoY
|
64.09B
55.42B – 82.42B
+0.1% YoY
|
| EBIT |
3.97B
est: 23.24B (-82.9%)
|
9.11B
est: 20.29B (-55.1%)
|
22.06B
est: 24.90B (-11.4%)
|
39.20B
est: 33.89B (+15.7%)
|
30.04B
est: 28.28B (+6.2%)
|
-22.76B
est: 18.10B (-225.7%)
|
33.44B
est: 23.80B (+40.5%)
|
70.16B
est: 33.92B (+106.9%)
|
37.26B
est: 51.59B (-27.8%)
|
34.78B
est: 40.62B (-14.4%)
|
33.50B
est: 36.47B (-8.2%)
|
43.02B
34.89B – 58.83B
+18.0% YoY
|
39.61B
36.63B – 47.30B
-7.9% YoY
|
39.62B
34.26B – 50.95B
+0.0% YoY
|
40.30B
34.85B – 51.83B
+1.7% YoY
|
40.33B
34.87B – 51.87B
+0.1% YoY
|
| Net Income |
1.94B
est: 10.83B (-82.1%)
|
4.58B
est: 6.41B (-28.6%)
|
12.98B
est: 11.84B (+9.6%)
|
23.35B
est: 17.21B (+35.7%)
|
15.84B
est: 13.17B (+20.3%)
|
-21.68B
est: 4.03B (-638.5%)
|
20.10B
est: 15.06B (+33.5%)
|
42.31B
est: 33.31B (+27.0%)
|
19.36B
est: 23.28B (-16.8%)
|
16.09B
est: 25.08B (-35.8%)
|
18.21B
est: 24.73B (-26.3%)
|
26.69B
18.79B – 34.59B
+7.9% YoY
|
24.97B
17.00B – 32.93B
-6.5% YoY
|
34.18B
24.44B – 34.46B
+36.9% YoY
|
29.97B
24.70B – 41.11B
-12.3% YoY
|
32.12B
26.47B – 44.06B
+7.2% YoY
|
| SGA |
11.96B
est: 11.90B (+0.5%)
|
12.10B
est: 10.39B (+16.5%)
|
10.51B
est: 12.75B (-17.6%)
|
11.36B
est: 17.35B (-34.5%)
|
10.49B
est: 14.48B (-27.5%)
|
9.88B
est: 9.27B (+6.6%)
|
11.33B
est: 12.19B (-7.0%)
|
12.88B
est: 17.37B (-25.8%)
|
13.43B
est: 16.10B (-16.5%)
|
12.44B
est: 12.67B (-1.8%)
|
12.87B
est: 11.38B (+13.1%)
|
13.42B
10.89B – 18.35B
+18.0% YoY
|
12.36B
11.43B – 14.76B
-7.9% YoY
|
12.36B
10.69B – 15.90B
+0.0% YoY
|
12.57B
10.87B – 16.17B
+1.7% YoY
|
12.58B
10.88B – 16.18B
+0.1% YoY
|
| EPS |
0.31
est: 1.70 (-81.8%)
|
0.58
est: 1.01 (-42.4%)
|
1.58
est: 1.86 (-15.1%)
|
2.82
est: 2.70 (+4.3%)
|
1.97
est: 2.07 (-4.8%)
|
-2.76
est: 0.63 (-536.3%)
|
2.59
est: 2.37 (+9.5%)
|
5.76
est: 5.23 (+10.1%)
|
2.85
est: 3.58 (-20.4%)
|
2.55
est: 3.84 (-33.6%)
|
3.09
est: 3.18 (-2.9%)
|
4.75
3.16 – 5.81
+49.2% YoY
|
4.41
2.86 – 5.54
-7.1% YoY
|
4.65
4.11 – 5.79
+5.3% YoY
|
5.04
4.15 – 6.91
+8.4% YoY
|
5.40
4.45 – 7.41
+7.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Wael Sawan | Chief Executive Officer & Director | 5M | male |
| Sinead Gorman | Chief Financial Officer & Director | 3M | female |
| Brian Paul Eggleston | Executive Vice President of Finance Downstream | — | male |
| Cederic Cremers | President of Integrated Gas | — | male |
| Graham Robert van't Hoff | Executive Vice President of Chemicals | — | male |
| Machteld de Haan | President of Downstream, Renewables & Energy Solutions | — | female |
| Peter Costello | President of Upstream | — | male |
| Ali Al-Janabi | Chairman for Kazakhstan | — | male |
| Rachel Solway | Chief Human Resources & Corporate Officer | — | female |
| Robin Mooldijk | President of Projects & Technology | — | male |
| Roland Ilube | Senior Vice President of Finance Mobility | — | male |
| Sean Ashley | Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SHEL.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
